Purple Biotech (PPBT) Interest & Investment Income (2014 - 2026)
Purple Biotech (PPBT) reported Interest & Investment Income of -$20000.0 for Q1 2026, up 62.96% year-over-year from -$12272.7 in Q1 2025, and up 95.28% quarter-over-quarter from -$424000.0 in Q4 2025.
Purple Biotech (PPBT) Interest & Investment Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Interest & Investment Income data on file, last reported at -$20000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$20000.0, up 62.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20000.0 (up 62.96% YoY), and the FY2025 annual result was -$424000.0, up 51.15% from the prior year.
- Interest & Investment Income grew to -$20000.0 in Q1 2026 per PPBT's latest filing, from -$424000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at -$20000.0 in Q1 2026 and troughed at -$1.1 million in Q3 2023.
- A 5-year average of -$394470.6 and a median of -$282000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income plunged 396.43% in 2023, then soared 65.83% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at -$843000.0 in 2022, then fell by 17.67% to -$992000.0 in 2023, then grew by 12.5% to -$868000.0 in 2024, then jumped by 51.15% to -$424000.0 in 2025, then surged by 95.28% to -$20000.0 in 2026.
- Business Quant data shows PPBT's Interest & Investment Income at -$20000.0 in Q1 2026, -$424000.0 in Q4 2025, and -$228000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | -424,000.00 |
| Sep 30, 2025 | -228,000.00 |
| Jun 30, 2025 | -106,000.00 |
| Mar 31, 2025 | -54,000.00 |
| Dec 31, 2024 | -868,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | -992,000.00 |
| Sep 30, 2023 | -1.11 Mn |
| Jun 30, 2023 | -401,000.00 |
| Mar 31, 2023 | -278,000.00 |
| Dec 31, 2022 | -843,000.00 |
| Sep 30, 2022 | -393,000.00 |
| Jun 30, 2022 | -145,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -320,000.00 |
| Sep 30, 2021 | -264,000.00 |
| Jun 30, 2021 | -196,000.00 |